Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

NCT00038519 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Evaluation of Kaletra Therapy Over the Long-term

NCT01083810 ·Status: COMPLETED

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

NCT01153269 ·Status: COMPLETED

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

NCT00648999 ·Status: COMPLETED ·Phase: PHASE4

Kaletra and Viread in Antiretroviral Naïve Patients

NCT00679926 ·Status: TERMINATED ·Phase: PHASE4

Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen

NCT00200369 ·Status: COMPLETED

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

NCT00038532 ·Status: COMPLETED ·Phase: PHASE2

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

NCT00116636 ·Status: COMPLETED ·Phase: PHASE2

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

NCT01097655 ·Status: COMPLETED

Induction-maintenance of Lopinavir/r in HIV-infected Subjects

NCT00159224 ·Status: COMPLETED ·Phase: PHASE4

NRTI-Sparing Pilot Study

NCT00143689 ·Status: COMPLETED ·Phase: PHASE4

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

NCT00335686 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients

NCT00140751 ·Status: COMPLETED ·Phase: PHASE3

Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection

NCT01328158 ·Status: COMPLETED

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

NCT01237444 ·Status: COMPLETED ·Phase: PHASE3

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

NCT01074931 ·Status: COMPLETED

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

NCT00931463 ·Status: COMPLETED ·Phase: PHASE4

A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence

NCT00785616 ·Status: COMPLETED ·Phase: PHASE4

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

NCT00028301 ·Status: COMPLETED ·Phase: PHASE3

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

NCT00046033 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

NCT00025727 ·Status: UNKNOWN ·Phase: PHASE3

Kaletra-isentress Treatment Evaluation

NCT00700115 ·Status: COMPLETED ·Phase: PHASE4

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

NCT00414284 ·Status: TERMINATED ·Phase: PHASE4

GW873140 In Combination With Kaletra In HIV Infected Subjects

NCT00102778 ·Status: TERMINATED ·Phase: PHASE2

Drug Use Investigation of Kaletra

NCT01076972 ·Status: COMPLETED